Evaluation of the Single-dose Pharmacokinetics of Bilastine in Subjects with Various Degrees of Renal Insufficiency

被引:0
|
作者
Kenneth C. Lasseter
Ander Sologuren
Anna La Noce
Stacy C. Dilzer
机构
[1] Clinical Pharmacology of Miami,
[2] Inc. (CPMI),undefined
[3] FAES FARMA,undefined
[4] S.A.,undefined
[5] inVentiv Health Clinical,undefined
来源
关键词
Glomerular Filtration Rate; Renal Insufficiency; Plasma Protein Binding; Breast Cancer Resistance Protein; Impaired Group;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:665 / 673
页数:8
相关论文
共 50 条
  • [1] Evaluation of the Single-dose Pharmacokinetics of Bilastine in Subjects with Various Degrees of Renal Insufficiency
    Lasseter, Kenneth C.
    Sologuren, Ander
    La Noce, Anna
    Dilzer, Stacy C.
    [J]. CLINICAL DRUG INVESTIGATION, 2013, 33 (09) : 665 - 673
  • [2] Pharmacokinetics of intravenous, single-dose tiotropium in subjects with different degrees of renal impairment
    Türck, D
    Weber, W
    Sigmund, R
    Budde, K
    Neumayer, HH
    Fritsche, L
    Rominger, KL
    Feifel, U
    Slowinski, T
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (02): : 163 - 172
  • [3] Pharmacokinetics of single-dose reboxetine in volunteers with renal insufficiency
    Coulomb, F
    Ducret, F
    Laneury, JP
    Fiorentini, F
    Poggesi, I
    Jannuzzo, MG
    Fleishaker, JC
    Houin, G
    Duchêne, P
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (05): : 482 - 487
  • [4] PHARMACOKINETICS OF A SINGLE INTRAVENOUS DOSE OF TEICOPLANIN IN SUBJECTS WITH VARIOUS DEGREES OF RENAL IMPAIRMENT
    BONATI, M
    TRAINA, GL
    ROSINA, R
    BUNIVA, G
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 21 : 29 - 37
  • [5] Single-dose pharmacokinetics of temocapril and temocapril diacid in subjects with varying degrees of renal impairment
    B. Sierakowski
    K. Püchler
    P. U. Witte
    K. Renneisen
    I. Roots
    [J]. European Journal of Clinical Pharmacology, 1997, 53 : 215 - 220
  • [6] Single-dose pharmacokinetics of temocapril and temocapril diacid in subjects with varying degrees of renal impairment
    Sierakowski, B
    Püchler, K
    Witte, PU
    Renneisen, K
    Roots, I
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 53 (3-4) : 215 - 220
  • [7] SINGLE-DOSE PHARMACOKINETICS OF ALP2011 IN SUBJECTS WITH VARIOUS DEGREES OF HEPATIC IMPAIRMENT.
    Michaud, J.
    Fazio, C.
    Boily, S.
    Massicotte, J.
    Sicard, E.
    Lefebvre, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S77 - S77
  • [8] SINGLE-DOSE PHARMACOKINETICS OF RECOMBINANT HUMAN ERYTHROPOIETIN IN PATIENTS WITH VARIOUS DEGREES OF RENAL-FAILURE
    KINDLER, J
    ECKARDT, KU
    EHMER, B
    JANDELEIT, K
    KURTZ, A
    SCHREIBER, A
    SCIGALLA, P
    SIEBERTH, HG
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1989, 4 (05) : 345 - 349
  • [9] PHARMACODYNAMICS AND PHARMACOKINETICS OF SINGLE-DOSE RAMIPRIL IN HYPERTENSIVE PATIENTS WITH VARIOUS DEGREES OF RENAL-FUNCTION
    SHIONOIRI, H
    IKEDA, Y
    KIMURA, K
    MIYAKAWA, T
    KANEKO, Y
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1986, 40 (01): : 74 - 85
  • [10] Single-dose pharmacokinetics of ibrutinib in subjects with varying degrees of hepatic impairment
    de Jonga, Jan
    Skee, Donna
    Hellemans, Peter
    Jiao, James
    de Vries, Ronald
    Swerts, Dominique
    Lawitz, Eric
    Marbury, Thomas
    Smith, William
    Sukbuntherng, Juthamas
    Mannaert, Erik
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 (01) : 185 - 194